Treatment Outcomes of 9,994 Patients With Extensive-Disease Small-Cell Lung Cancer From a Retrospective Nationwide Population-Based Cohort in the Korean HIRA Database.

Front Oncol · 2021 · PMC8019929 · PMID 33828968

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

a favorable trendP = 0.120not close (p > 0.1)

In a recent phase III trial in Korean patients with ED-SCLC, although OS and PFS were not significantly different between the EP and IP arms, there was a favorable trend toward the IP regimen (OS, 10.9 months vs. 10.3 months, P = 0.120; PFS, 6.5 months vs. 5.8 months, P = 0.115).

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.